These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26712589)

  • 41. Oral mucositis.
    Raber-Durlacher JE; Elad S; Barasch A
    Oral Oncol; 2010 Jun; 46(6):452-6. PubMed ID: 20403721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of indomethacin oral spray for the treatment of oropharyngeal mucositis-induced pain during anticancer therapy.
    Momo K; Nagaoka H; Kizawa Y; Bukawa H; Chiba S; Kohda Y; Homma M
    Support Care Cancer; 2017 Oct; 25(10):2997-3000. PubMed ID: 28711976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity.
    Bossi P; Cossu Rocca M; Corvò R; Depenni R; Guardamagna V; Marinangeli F; Miccichè F; Trippa F
    Crit Rev Oncol Hematol; 2017 Aug; 116():82-88. PubMed ID: 28693802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer.
    Batth SS; Caudell JJ; Chen AM
    Head Neck; 2014 Feb; 36(2):291-8. PubMed ID: 23508721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of oral mucositis in patients who have cancer.
    Lalla RV; Sonis ST; Peterson DE
    Dent Clin North Am; 2008 Jan; 52(1):61-77, viii. PubMed ID: 18154865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
    Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations.
    Zecha JA; Raber-Durlacher JE; Nair RG; Epstein JB; Sonis ST; Elad S; Hamblin MR; Barasch A; Migliorati CA; Milstein DM; Genot MT; Lansaat L; van der Brink R; Arnabat-Dominguez J; van der Molen L; Jacobi I; van Diessen J; de Lange J; Smeele LE; Schubert MM; Bensadoun RJ
    Support Care Cancer; 2016 Jun; 24(6):2781-92. PubMed ID: 26984240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review.
    Ahn MJ; D'Cruz A; Vermorken JB; Chen JP; Chitapanarux I; Dang HQ; Guminski A; Kannarunimit D; Lin TY; Ng WT; Park KU; Chan AT
    Oral Oncol; 2016 Feb; 53():10-6. PubMed ID: 26712252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).
    Mañós M; Giralt J; Rueda A; Cabrera J; Martinez-Trufero J; Marruecos J; Lopez-Pousa A; Rodrigo JP; Castelo B; Martínez-Galán J; Arias F; Chaves M; Herranz JJ; Arrazubi V; Baste N; Castro A; Mesía R
    Oral Oncol; 2017 Jul; 70():58-64. PubMed ID: 28427761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2).
    Rueda A; Giralt J; Mañós M; Lozano A; Sistiaga A; García-Miragall E; Cacicedo J; Esteban F; Scola B; Contreras J; Ruiz A; Carral A; Sanchez-Aniceto G; Pastor M; Herranz JJ; Bernal M; Mesía R
    Oral Oncol; 2017 Jul; 70():65-72. PubMed ID: 28427762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study.
    Franco P; Potenza I; Moretto F; Segantin M; Grosso M; Lombardo A; Taricco D; Vallario P; Filippi AR; Rampino M; Ricardi U
    Radiat Oncol; 2014 Dec; 9():297. PubMed ID: 25544371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients.
    Franco P; Rampino M; Ostellino O; Schena M; Pecorari G; Garzino Demo P; Fasolis M; Arcadipane F; Martini S; Cavallin C; Airoldi M; Ricardi U
    Med Oncol; 2017 Feb; 34(2):30. PubMed ID: 28101834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
    Marucci L; Farneti A; Di Ridolfi P; Pinnaro P; Pellini R; Giannarelli D; Vici P; Conte M; Landoni V; Sanguineti G
    Head Neck; 2017 Sep; 39(9):1761-1769. PubMed ID: 28560780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Confounding factors in the assessment of oral mucositis in head and neck cancer.
    Lorini L; Perri F; Vecchio S; Belgioia L; Vinches M; Brana I; Elad S; Bossi P
    Support Care Cancer; 2022 Oct; 30(10):8455-8463. PubMed ID: 35639187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of oral mucositis, its treatment and pain management in patients receiving cancer treatment at Radiation Oncology Departments in Spanish hospitals (MUCODOL Study).
    Mañas A; Palacios A; Contreras J; Sánchez-Magro I; Blanco P; Fernández-Pérez C
    Clin Transl Oncol; 2009 Oct; 11(10):669-76. PubMed ID: 19828409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of mucositis on quality of life in patients with head and neck cancer.
    Armstrong JA; McCaffrey R
    Clin J Oncol Nurs; 2006 Feb; 10(1):53-6. PubMed ID: 16482728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mucositis: biology and management.
    Treister N; Sonis S
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):123-9. PubMed ID: 17413415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations.
    Pinto C; Barone CA; Girolomoni G; Russi EG; Merlano MC; Ferrari D; Maiello E
    Am J Clin Oncol; 2016 Aug; 39(4):407-15. PubMed ID: 27077276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy.
    Zenda S; Matsuura K; Tachibana H; Homma A; Kirita T; Monden N; Iwae S; Ota Y; Akimoto T; Otsuru H; Tahara M; Kato K; Asai M
    Radiother Oncol; 2011 Dec; 101(3):410-4. PubMed ID: 22001102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises.
    Kraaijenga SA; van der Molen L; Jacobi I; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3521-31. PubMed ID: 25381096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.